Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    17369569 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iobenguane I 131
2 Not yet recruiting Phase I Study of Investigational Medicinal Products in Children With Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Nivolumab;   Drug: Ch14.18/CHO

Study has passed its completion date and status has not been verified in more than two years.